QuickView for thyroid-stimulating hormone signaling pathway (biogroup)

1. OMIM - Thyroid disease
2. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
4. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
5. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens

There were no matches for thyroid-stimulating hormone signaling pathway

1. Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib
2. Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyro…
3. Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer
4. Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes
5. Gastrointestinal Hormonal Regulation of Obesity